drugset / Trial / NCT00703859

Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma

NCT00703859 ↗

Phase 1 Withdrawn AHS Cancer Control Alberta
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a study to see whether radiotherapy plus chemotherapy (Temozolomide) plus Dichloroacetate (DCA) improves overall survival and offers better control of the disease in patients with newly diagnosed Glioblastoma Multiforme Tumours.

Timeline

Start
2008-07
Primary completion
2010-01
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject DICHLOROACETIC ACID Small molecule 3 mg/kg Oral

Indications